Stock Market News

Amgen owes $406 million for monopolizing cholesterol drug market, US jury says

May 15, 2025 - 22:28
 0
Amgen owes $406 million for monopolizing cholesterol drug market, US jury says
Read More

Tags:

Previous Article

CoreWeave shares end lower as OpenAI deal fails to calm spending worries

Next Article

Trump announces $200 billion in deals during UAE visit, AI agreement signed

Related Posts

Polestar leans on 'home market' Europe to revive business; posts smaller Q1 loss

Polestar leans on 'home market' Europe to revive busine...

May 12, 2025  0

Canada stocks higher at close of trade; S&P/TSX Composi...

May 8, 2025  0

Mexico stocks higher at close of trade; S&P/BMV IPC up 0.05%

Mexico stocks higher at close of trade; S&P/BMV IPC up ...

May 16, 2025  0